Peters Anomaly.
Zhang Z, Syed NA, Alward WLM.
Ophthalmol Glaucoma. 2019 Jul-Aug;2(4):266. doi: 10.1016/j.ogla.2019.03.005.
[Circular corneal opacities].
Rohrbach JM, Nölle B, Amm M, Lisch W.
Ophthalmologe. 2001 Jul;98(7):674-96; quiz 697, 699. doi: 10.1007/s003470170107.
[Keratography (corneal tattooing) in corneal leukoma].
Schaller UC, van der Velden EM, Drost BH, Weede S, Klauss V.
Ophthalmologe. 2001 Feb;98(2):147-50. doi: 10.1007/s003470170175.
Corneal Leukoma with Features of Both Sclerocornea and Peter's Anomaly.
Raven ML, Rodriguez ME, Potter HD.
Ophthalmology. 2016 Sep;123(9):1988. doi: 10.1016/j.ophtha.2016.05.011.
Cellular and extracellular matrix modulation of corneal stromal opacity.
Torricelli AA, Wilson SE.
Exp Eye Res. 2014 Dec;129:151-60. doi: 10.1016/j.exer.2014.09.013. Epub 2014 Oct 1.
Corneal snowflakes.
Huang YH, Tseng SH.
Lancet. 2012 Aug 4;380(9840):506. doi: 10.1016/S0140-6736(12)60162-7. Epub 2012 May 7.
Periostin Deletion Reduces Corneal Opacity and the Infiltration of Immune Cells.
Seong H, Song C, Kim M, Yoo WS, Choi MY, Varga RD, Choe YH, Lee B, Yun SP, Yoo YS, Eom Y, Joo CK, Yang J, Kim SJ.
Am J Pathol. 2026 Feb;196(2):550-561. doi: 10.1016/j.ajpath.2025.09.007. Epub 2025 Sep 30.
Congenital central corneal leukoma (Peters' anomaly).
Stone DL, Kenyon KR, Green WR, Ryan SJ.
Am J Ophthalmol. 1976 Feb;81(2):173-93. doi: 10.1016/0002-9394(76)90729-7.
Histopathology of corneal leukoma and fibroma in the ACL syndrome.
Azar P Jr, Rothschild H, Rosenthal JW, Ichinose H.
Hum Pathol. 1983 Feb;14(2):188-90. doi: 10.1016/s0046-8177(83)80251-2.
Suppression of lipopolysaccharide-induced corneal opacity by hepatocyte growth factor.
Elbasiony E, Cho W, Mittal SK, Chauhan SK.
Sci Rep. 2022 Jan 11;12(1):494. doi: 10.1038/s41598-021-04418-x.
